CD8A and breast carcinoma: In breast cancer patients, complete remission in 60% of the combination treatment group in breast cancer patients and there was a significant increase in CD4+ and CD8+ T-cell infiltration and a decrease in MDSCs, M1-type macrophages, and Treg cell infiltration were observed [111].